/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/ncds-knowledge-action-portal.jpg?sfvrsn=d75056b8_4 "NCDs knowledge action portal")
Knowledge Action Portal on NCDs
Take a look behind the scenes of the Knowledge Action Portal (KAP).
Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.
NCD data portal
Explore the data by country
On the road to 2025 and beyond
/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/on-the-road-to-2025-countdown-days.jpg?sfvrsn=7d7b21e4_79 "On the road to 2025 countdown days")
HLM4: On the road to 2025 and beyond
Preparatory process for the Fourth High-level Meeting of the UN General Assembly on the prevention and control of NCDs (HLM4)
/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/un-general-assembly-meeting-room.jpg?sfvrsn=b07fcc1d_7 "UN General Assembly meeting room")
Implementation roadmap 2023–2030
for the Global action plan for the prevention and control of NCDs 2013–2030
Related links
Related events and news
New publication
Related publications and documents
Other departmental work
Related health topics
Noncommunicable diseases
WHO / EURO /Gilles Reboux
©
Credits
Cancer
Cancer
Technical links
Sensory functions, disability and rehabilitation
Risk factors
Other related health topics
Latest publications
All →The goal of the Paediatric drug optimization for cancer exercise was to develop a PADO priority list of formulations to be prioritized with a time horizon...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 3: establishing...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and,...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing...
When considering a multisectoral action plan (MSAP), it is important to take into account various issues relating to its implementation. Implementation is...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 1: conducting...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: overview
This toolkit is a "how to" guide for developing, implementing and evaluating a multisectoral action plan for prevention and control of NCDs. It is targeted...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 5: evaluating...
Key stakeholders must be involved in the planning, implementation, monitoring and evaluation of NCD plans and programmes. Within a ministry of health there...
19 April 2022
Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 2: establishing...
To maintain a structured and well-organized implementation plan it is important to have a lead agency or sector. The ministry of health or a similar...
8 December 2020
WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer
This document brings a new focus to the management of invasive disease in the comprehensive control and eventual elimination of cervical cancer. Aligned...
Feature stories
Fact sheets
Related links
Engagement with the private sector
Noncommunicable diseases and COVID-19